Key result
Arrhythmogenic right ventricular cardiomyopathy is a globally recognized inherited heart disease without specific racial or geographical predilection, requiring international collaboration for diagnosis and management.
This review highlights that ARVC is a global disease without specific geographic predilection, emphasizing the importance of international registries and screening programs to prevent sudden cardiac death.
Supports global ARVC registries to curb SCD; leaves open ancestry-specific phenotypic studies.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a progressive inherited heart disease characterized by ventricular arrhythmias and sudden cardiac death especially in the young. ARVC has been traditionally associated with the Mediterranean basin, as many seminal studies on the disease have originated from research groups of this region. Today, however, numerous ARVC registries from all over the world emphasize that the disease does not have a specific racial or geographical predilection. This work provides a review on the global perspective of ARVC.
No takes yet. Share an insight, caveat, or question.
ElMaghawry et al. (2012) conducted a review in Arrhythmogenic right ventricular cardiomyopathy (ARVC). Arrhythmogenic right ventricular cardiomyopathy is a globally recognized inherited heart disease without specific racial or geographical predilection, requiring international collaboration for diagnosis and management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: